In plain terms: antibiotics kill the bad bacteria and a lot of the good ones living in your gut. For about a month or two afterward, your gut is rebuilding — and what you take during that window decides how cleanly it bounces back.Stack-kit editorial
The antibiotics worked. Now your gut is in a 4–8 week recovery window: broad-spectrum courses can sharply reduce Bifidobacterium and Lactobacillus populations, transiently raise intestinal permeability (the gut wall is briefly a little leakier than usual), and open a dysbiotic window — meaning the bacterial mix is temporarily off-balance — that invites opportunistic pathogens. The response is not "reseed everything forever." The evidence is narrower: use named strains for antibiotic-associated diarrhea risk, introduce fermentable fiber only after the acute window, and avoid cleanse products that work against recovery. What follows names four evidence-backed items by strain ID and mechanism, gives you dose and timing, points you to specific brands, and calls out six popular "gut cleanse" products that actively work against recovery.
We sell against the cleanse category here, so let's be blunt about why up front.
The Short Version
If you read nothing else, read this. Four items, run together for about eight weeks, roughly $80–140 for the whole course.
- Saccharomyces boulardii CNCM I-745 (Florastor) — concurrent with antibiotics through 2 weeks post; 500 mg during, 1,000 mg after
- Lactobacillus rhamnosus GG ATCC 53103 (Culturelle) — 10 billion CFU/day from end of antibiotics through week 6
- Partially hydrolyzed guar gum / PHGG (Sunfiber) — 5–10 g/day starting week 2 post-antibiotics; the prebiotic scaffold that feeds what you're reseeding
- L-Glutamine powder (Thorne) — 5–10 g/day for 4 weeks; epithelial barrier support while tight-junction proteins recover
Read this before you start. If your antibiotic course was narrow-spectrum and short — one dental amoxicillin dose, no GI symptoms — this full protocol is overcalibrated for your situation. And if you had confirmed C. difficile infection, not just antibiotic-associated diarrhea, consult gastroenterology before starting any probiotic; the timing picture changes.
Buy the items individually, not as a bundle. No bundle on the market matches this strain-specific combination. We looked.
The Protocol — Detailed
Why "Gut Cleanse" Products Work Against You Here
Here's what most people get wrong: they finish a course of antibiotics, feel a little off, and reach for a "cleanse." The instinct is understandable and the mechanism is backwards.
The colon is not a passive waste-storage vessel with accumulated gunk waiting to be flushed. Broad-spectrum antibiotics reduce commensal Lactobacillus and Bifidobacterium counts within days and open a 4–8 week dysbiotic window during which Clostridioides difficile and other antibiotic-resistant enteropathogens can move in. The way back isn't flushing — and it also is not a blanket "probiotics rebuild the microbiome" claim. The controlled human evidence is more awkward: Suez et al. 2018 found that an 11-strain probiotic delayed and impaired the native mucosal microbiome's return after antibiotics compared with spontaneous recovery, while autologous FMT restored fastest. So the honest protocol is specific, not maximalist: named strains for antibiotic-associated diarrhea risk, delayed fermentable fiber once the gut is calmer, and barrier support when the course was broad or symptomatic. None of that is a "cleanse." Worse: stimulant laxatives — the active ingredient in most detox teas — thin the mucosal layer and flush out the very commensal bacteria you're trying to bring back.
One legitimate mechanism deserves to be rescued from the marketing. Intestinal permeability — how easily things slip across the gut wall — is real and measurable. Post-antibiotics, tight-junction proteins (ZO-1, claudin-1, occludin) show transiently reduced expression, quantifiable via the lactulose/mannitol ratio (a urine test that gauges how leaky the gut wall is). That measurable phenomenon is the actual reason L-glutamine earns a slot in this protocol. It is not the same thing as the wellness-industry version of "leaky gut" — the unfalsifiable umbrella diagnosis blamed for fatigue, brain fog, and skin issues with no validated biomarkers behind it. Same two words, different construct.
Saccharomyces boulardii CNCM I-745
Saccharomyces boulardii CNCM I-745 — concurrent + post-antibiotic
INPeel back the label
Mechanism
S. boulardii is a tropical yeast — not a bacterium — which means antibacterial drugs do not affect it. During an active antibiotic course, S. boulardii exerts three documented mechanisms: competitive exclusion of Clostridioides difficile toxin receptor binding at the colonocyte surface; upregulation of secretory IgA (sIgA) in the intestinal mucosa; and secretion of a serine protease (54 kDa) that directly cleaves C. diff toxin A and toxin B into inactive fragments. It does not colonize permanently — clearance occurs within 3–5 days of stopping supplementation — making it a bridging agent during active antibiotic use, not a long-term resident.
Evidence
Goldenberg JZ et al. (2015), Cochrane Database of Systematic Reviews: S. boulardii sub-analysis RR = 0.49 (95% CI 0.38–0.63), NNT = 10, N = 3,027 across 21 RCTs. The 51% reduction in antibiotic-associated diarrhea incidence is the most consistent finding in the post-antibiotic probiotic literature and the primary reason this item leads the protocol.
Skip when
Immunocompromised populations (HIV with CD4 < 200, active chemotherapy, solid-organ transplant on immunosuppression) — case reports of S. boulardii fungemia exist in severely immunocompromised patients; physician review is warranted before starting. Central venous catheter in place: same fungemia-risk concern. Confirmed concurrent systemic fungal infection. History of hypersensitivity to yeast products.
Start here, and start it while you're still on the antibiotics. This one's a yeast, so the antibiotics ignore it — which is exactly why it leads.
Mechanism. S. boulardii is a tropical yeast, not a bacterium, so antibacterial drugs don't touch it. During an active antibiotic course it does three documented things: it competitively blocks C. difficile toxin from binding its receptor at the colonocyte surface; it upregulates secretory IgA (an antibody that patrols the gut lining) in the intestinal mucosa; and it secretes a 54 kDa serine protease — an enzyme that snips C. diff toxin A and toxin B into inactive fragments. It does not permanently colonize; it clears within 3–5 days of stopping. So treat it as a bridging agent for the concurrent antibiotic window, not a long-term resident.
Dose. 500 mg/day during the antibiotic course (250 mg twice daily). Increase to 1,000 mg/day for 2 weeks post-antibiotics, then stop. No separation from antibiotic doses required — this is the single most important timing instruction on the page. Unlike bacterial probiotics, the yeast is unaffected by antibacterials, so you can take them together.
Brand. Florastor Daily Probiotic Supplement — 250 mg S. boulardii CNCM I-745 per capsule, and the strain identifier printed on the label matches the clinical trial strain exactly. Roughly $30 for 30 capsules at major pharmacies. Don't substitute a generic S. boulardii product that drops the CNCM I-745 designation; other isolates exist, and they haven't been studied to the same standard. That label code is the whole point.
Evidence. Goldenberg JZ et al. (2015), Cochrane Database of Systematic Reviews: S. boulardii for prevention of C. diff-associated diarrhea, RR = 0.49 (95% CI 0.38–0.63), NNT = 10. N = 3,027 across 21 RCTs. McFarland et al. 1994, JAMA, adds the crucial boundary: in recurrent C. diff, S. boulardii 1g/day plus standard antibiotics cut relapse to 34.6% vs 64.7% on placebo (RR 0.43), but it showed no significant benefit for first episodes (19.3% vs 24.2%, p=0.86). The 51% reduction in antibiotic-associated diarrhea incidence is the most consistent single finding in the entire post-antibiotic probiotic literature — but it does not mean every C. diff scenario or every low-risk antibiotic course needs a probiotic.
Skip it if: you're immunocompromised (HIV CD4 < 200, active chemotherapy, solid-organ transplant on immunosuppression) — S. boulardii fungemia cases are documented, so get physician review first. Same concern with a central venous catheter in place. Skip it with a confirmed concurrent systemic fungal infection, or a history of yeast hypersensitivity.
Lactobacillus rhamnosus GG (LGG, ATCC 53103)
Lactobacillus rhamnosus GG (LGG, ATCC 53103) — post-antibiotic seeding phase
INPeel back the label
Mechanism
LGG is the most-studied single probiotic strain for post-antibiotic gut ecology restoration in adults; SpaA, SpaB, and SpaC pilus proteins on the LGG cell surface mediate transient adhesion to intestinal epithelium sufficient to competitively exclude enteropathogens — Enterococcus faecalis, resistant E. coli, C. diff — during the 2–6 week dysbiotic window after antibiotics stop. LGG also upregulates mucin gene expression (MUC3), supporting recovery of the mucus layer that broad-spectrum antibiotics thin. This is not a generic Lactobacillus effect — other L. rhamnosus strains without the SpaC pili cluster have different adhesion profiles and should not be treated as interchangeable.
Evidence
Vanderhoof JA et al. (1999), Journal of Pediatrics: LGG reduced antibiotic-associated diarrhea incidence from 25% to 7.7% vs. placebo (p < 0.001; N = 188). Hempel S et al. (2012), JAMA: overall RR = 0.58 (95% CI 0.50–0.68); N = 3,818 across 12 qualifying RCTs within an 82-trial systematic review; LGG was the most represented single strain across qualifying trials.
Skip when
Patients with short bowel syndrome or confirmed probiotic-bacteremia risk (prior episode of Lactobacillus bacteremia). Patients already on a clinician-directed high-dose multi-strain protocol (VSL#3 or Visbiome for active IBD flare) — LGG is not additive in that context and introduces unnecessary strain competition. If the index event was confirmed C. diff infection (not just antibiotic-associated diarrhea without C. diff confirmation): consult gastroenterology before starting any probiotic.
This is the bacterium you reseed with once the antibiotics are done. It's the most-studied single probiotic strain for rebuilding an adult gut after antibiotics — start it as the course ends.
Mechanism. LGG was isolated by Gorbach and Goldin in 1983, patented in 1985, and is now taxonomically classified as Lacticaseibacillus rhamnosus GG under the Zheng et al. 2020 reclassification. It carries SpaA, SpaB, and SpaC pilus proteins — tiny surface hooks — that let it grab onto the intestinal lining transiently (hours to days, not permanent colonization), and that's enough to crowd out enteropathogens like Enterococcus faecalis, resistant E. coli, and C. diff during the dysbiotic recovery window. It also upregulates mucin gene expression (MUC3), which helps rebuild the mucus layer the antibiotics thinned out. Note the catch: other L. rhamnosus strains lacking the SpaC pili cluster have different adhesion profiles, and they are not interchangeable with the research below.
Dose. 10 billion CFU/day (one capsule). If you're still on antibiotics, take LGG at least 2 hours after each antibiotic dose — unlike S. boulardii, LGG is a bacterium and gets killed by antibacterials, so it needs the gap. Once the antibiotics are finished, start immediately, no separation needed. Continue 4–6 weeks.
Brand. Culturelle Health & Wellness Daily Probiotic — 10 billion CFU LGG per capsule, ATCC 53103 confirmed, with an inulin prebiotic carrier included. About $25 for 30 capsules. The strain code ATCC 53103, or LGG, must be on the label. A bottle that just says "Lactobacillus rhamnosus" with no strain code can't be evaluated against this literature — and an untraceable strain is not worth your money here.
Evidence. Vanderhoof JA et al. (1999), Journal of Pediatrics: LGG cut antibiotic-associated diarrhea from 25% to 7.7% versus placebo (p < 0.001; N = 188). Hempel S et al. (2012), JAMA: a meta-analysis with overall RR = 0.58 (95% CI 0.50–0.68), in which LGG was the most represented single strain across 12 qualifying RCTs inside an 82-trial systematic review. Szajewska & Kołodziej 2015 sharpen the dose threshold: LGG's AAD effect concentrated at ≥10¹⁰ CFU/day and was significant primarily in children. The effect size is moderate and consistent — and that pairing of words is the point. Moderate-but-reliable beats spectacular-but-unrepeatable every time, but mega-dose CFU above the studied threshold is not a quality proxy.
Skip it if: you have short bowel syndrome or a prior episode of Lactobacillus bacteremia. Skip it, too, if you're already on a clinician-directed high-dose multi-strain protocol (VSL#3 / Visbiome) for an active IBD flare — LGG isn't additive in that context. And with confirmed C. diff infection (again, not just antibiotic-associated diarrhea): consult gastroenterology before starting, because probiotic timing relative to C. diff treatment has mixed evidence and genuinely matters.
Partially Hydrolyzed Guar Gum (PHGG)
Partially hydrolyzed guar gum (PHGG) — prebiotic scaffold, weeks 2–8
INPeel back the label
Mechanism
PHGG is a soluble, fermentable fiber (molecular weight ~20,000 Da; enzymatically hydrolyzed from guar gum, water-soluble, forms no gel at supplemental doses) that selectively feeds Bifidobacterium and Lactobacillus species — the primary genera depleted by broad-spectrum antibiotics — via fermentation to short-chain fatty acids (SCFAs). Butyrate is the primary metabolic fuel for colonocytes; propionate signals gut motility through enteroendocrine L-cell GPR43/GPR41 receptors. The 1-week delay before starting PHGG is deliberate: in the immediate post-antibiotic window, if residual pathogenic overgrowth is present, fermentable fiber fed to the wrong organisms worsens symptoms.
Evidence
Rao TP and Quartarone G (2015), Journal of the American College of Nutrition: PHGG at 5–10 g/day modified colonic microbiota composition toward Bifidobacterium and Lactobacillus dominance vs. baseline over an 8-week period (N = 60, placebo-controlled). Giannini EG et al. (2006), Alimentary Pharmacology & Therapeutics: PHGG improved stool consistency and symptom scores in IBS (N = 68; p < 0.05).
Skip when
Active Clostridioides difficile infection — fermentable fiber can worsen acute C. diff colitis; defer PHGG until C. diff is cleared. Confirmed SIBO (small intestinal bacterial overgrowth, diagnosed by lactulose or glucose breath test) — PHGG will worsen SIBO symptoms; treat SIBO first. Acute FODMAPs-sensitive IBS with ongoing flare — if bloating and pain are acute, defer PHGG or taper in at 1 g/day with very slow escalation. Inflammatory bowel disease in active flare — consult gastroenterologist before adding fermentable fiber.
This is the food for the bacteria you just reseeded. Probiotics without something to feed them is half a plan — PHGG is the fiber that does the feeding. Hold it back until week 2, though, and the next paragraph explains why.
Mechanism. PHGG is a soluble, fermentable fiber (molecular weight ~20,000 Da; enzymatically hydrolyzed, water-soluble, and it forms no gel at supplemental doses). It selectively feeds Bifidobacterium and Lactobacillus — precisely the genera antibiotics hit hardest — by fermenting into short-chain fatty acids (SCFAs). Those SCFAs earn their keep independently of the bifidogenic effect: butyrate is the primary metabolic fuel for colonocytes, and propionate signals gut motility through enteroendocrine L-cell GPR43/GPR41 receptors. The one-week delay before starting PHGG is deliberate — in the immediate post-antibiotic window, if there's still pathogenic overgrowth hanging around, fermentable fiber fed to the wrong organisms can make symptoms worse. That caution is not just vibes: inulin-type fructans delayed recovery of antibiotic-induced colitis in a 2020 prebiotic study (PubMed 32813896). PHGG is not inulin, but the principle is useful: hold concentrated fermentable fiber until the gut has settled, then ramp slowly.
Dose. 5 g/day for weeks 1–2 of PHGG use; 10 g/day for weeks 3–8. Begin in week 2 post-antibiotics, not week 1. PHGG is colorless, flavorless, and dissolves completely in any liquid — coffee, water, whatever you're already drinking. Take it with the first meal of the day so it anchors to a habit. That 2-week ramp exists to soften the transient bloating some people report at the full 10 g/day.
Brand. Sunfiber by Taiyo International — 100% PHGG, Non-GMO Project Verified, enzymatically hydrolyzed to the same 20,000 Da fraction used in the RCTs below. Around $25 for 250 g (50 servings at 5 g). Psyllium is not a substitute — different fermentation kinetics, different microbiome selectivity. Generic inulin isn't a substitute either — it produces more gas at equivalent doses, which during recovery is the opposite of what you want.
Evidence. Rao TP and Quartarone G (2015), Journal of the American College of Nutrition: PHGG at 5–10 g/day shifted colonic microbiota toward Bifidobacterium and Lactobacillus dominance versus baseline over 8 weeks (N = 60, placebo-controlled). Giannini EG et al. (2006), Alimentary Pharmacology & Therapeutics: PHGG improved stool consistency and IBS symptom scores (N = 68; p < 0.05), with the motility effect attributed to that SCFA-mediated enteroendocrine signaling.
Skip it if: you have an active C. difficile infection — fermentable fiber can worsen acute C. diff colitis, so defer until it clears. Skip it with confirmed SIBO (diagnosed by lactulose or glucose breath test) — PHGG will worsen SIBO symptoms; treat the SIBO first. In an acute FODMAPs-sensitive IBS flare, either taper in at 1 g/day with slow escalation or defer entirely. And with an active IBD flare, talk to your gastroenterologist before adding any fermentable fiber.
L-Glutamine Powder
L-Glutamine — gut epithelial barrier support, 4-week course
INPeel back the label
Mechanism
Intestinal epithelial cells use L-glutamine as their primary oxidative fuel source, ahead of glucose. Post-illness and post–broad-spectrum antibiotic gut epithelium shows transiently reduced tight-junction protein expression (ZO-1, occludin, claudin-1), quantifiable as increased lactulose/mannitol permeability ratio. Under physiological stress, glutamine becomes conditionally essential — endogenous synthesis insufficient to meet the metabolic demand of enterocyte renewal and concurrent immune activation in the gut lamina propria. Evidence grade: mechanism-supported extrapolation from clinical populations, not a direct RCT in healthy adults post-antibiotics.
Evidence
Lima NL et al. (2014), Clinical Nutrition: glutamine supplementation reduced intestinal permeability (lactulose/mannitol ratio) in children with acute diarrheal illness vs. placebo (N = 124; p < 0.01). Van der Hulst RR et al. (1993), Lancet: glutamine-enriched total parenteral nutrition maintained gut-barrier integrity vs. standard TPN in surgical ICU patients (N = 20; intestinal permeability reduced; p < 0.05). Evidence grade for this population: mechanism + extrapolation.
Skip when
Renal impairment (CKD stage 3 or higher) — glutamine is catabolized to ammonia in the liver and kidney; impaired clearance is a documented concern at supplemental doses. Hepatic encephalopathy — same ammonia-clearance reasoning; glutamine is contraindicated. Active seizure disorder on medication — some case-level reports suggest glutamine may lower seizure threshold via GABAergic modulation; caution warranted. If the antibiotic course was narrow-spectrum (single dental procedure amoxicillin with no GI symptoms) — the epithelial disruption in this scenario is unlikely to be clinically significant; skip glutamine.
This one supports the gut wall itself while it knits back together — not the bacteria, the actual lining. It's the most honest-about-its-evidence item in the stack, and we'll show our work below.
Mechanism. Intestinal epithelial cells burn L-glutamine as their primary fuel — ahead of glucose. After illness and after a broad-spectrum antibiotic course, the gut epithelium shows transiently reduced tight-junction protein expression (ZO-1, occludin, claudin-1), which reads out as an increased lactulose/mannitol permeability ratio. Under physiological stress, glutamine becomes conditionally essential — meaning your body normally makes enough on its own, but during recovery it can't keep pace with simultaneous enterocyte renewal and immune activation in the gut lamina propria. (Endogenous, here, just means "made by the body rather than swallowed.")
An honest accounting of the evidence. The mechanism is well-established — Wu 1998 is the landmark paper, and the enterocyte-fuel model is textbook physiology. But the strongest human RCT evidence for glutamine and gut permeability sits in critical illness and pediatric diarrheal disease, not in otherwise-healthy adults post-antibiotics specifically. So this entry is mechanism-supported extrapolation, and we'd rather say that out loud than let it pass as something firmer. The evidence grade belongs on the page, so here it is on the page.
Dose. 5 g/day for weeks 1–2; 10 g/day for weeks 3–4. Powder form. Take it on an empty stomach, or 30 minutes before the first meal — glutamine competes with other neutral amino acids at the intestinal ASCT2 transporters, so dosing it before meal protein arrives improves how much the enterocytes actually absorb. Stop after 4 weeks. This is a bridging supplement for the active repair window, not a forever habit.
Brand. Thorne Research L-Glutamine Powder — NSF Certified for Sport, made in a GMP-compliant facility, 100% L-glutamine, unflavored. Roughly $30 for 90 servings at 5 g. Thorne's third-party testing is what removes the contamination worry that comes with sourcing amino acid powders from generic bulk suppliers — which, with something you're taking precisely to repair a vulnerable gut lining, is not a corner to cut.
Evidence. Reeds PJ and Burrin DG (2001), Journal of Nutrition: the foundational mechanism paper establishing glutamine as conditionally essential for intestinal function. Lima NL et al. (2014), Clinical Nutrition: glutamine supplementation reduced intestinal permeability (lactulose/mannitol ratio) in children with acute diarrheal illness versus placebo (N = 124; p < 0.01). Van der Hulst RR et al. (1993), Lancet: glutamine-enriched TPN maintained gut-barrier integrity versus standard TPN in surgical ICU patients (N = 20; p < 0.05). Evidence grade for the general-adult post-antibiotic population: mechanism plus extrapolation from adjacent clinical populations. We're repeating that grade on purpose.
Skip it if: you're at CKD stage 3 or higher — glutamine catabolizes to ammonia, and impaired clearance is a documented concern at supplemental doses. Skip it with hepatic encephalopathy for the same ammonia-clearance reason; there it's contraindicated outright. With an active seizure disorder, discuss it with your clinician rather than self-directing; the evidence here is too thin for a blanket contraindication but enough to avoid casual use. And if your antibiotic course was narrow-spectrum and short with no GI symptoms, skip it: meaningful epithelial disruption in that scenario is unlikely.
What to Cut — 6 Products That Work Against This Protocol
Plain version: the shelf is full of things marketed for your gut that, during this specific window, set your recovery back. Here are the six we'd put down.
Generic high-CFU probiotics with no named strain IDs. "50 billion CFUs" is a dose number and nothing more. It tells you nothing about mechanism, adhesion, or colonization kinetics. Without ATCC, CNCM, or an equivalent strain-registry identifier on the label, the product can't be matched to a single clinical trial. Strain identity is the minimum entry requirement; anything less is buying a black box and hoping. And past the studied threshold — roughly 10¹⁰ CFU/day for LGG — bigger numbers have not been shown to buy more benefit.
Routinely throwing probiotics at the gut to "speed microbiome reconstitution." Use probiotics for the specific indication the trials actually tested: lowering antibiotic-associated diarrhea or higher-risk C. diff diarrhea risk with named strains. Do not buy them because a label says "rebuild your microbiome." Suez et al. 2018 found a commercial 11-strain probiotic delayed and impaired native mucosal microbiome recovery after antibiotics compared with spontaneous recovery; autologous FMT restored fastest. Specific prevention role, yes. Blanket restoration promise, no.
Activated charcoal "gut cleanse" products. Activated charcoal has one legitimate job: acute oral toxin ingestion in an emergency room. Take it post-antibiotics and it adsorbs medications — including whatever you're still recovering from — drags down nutrient absorption, and does nothing for reseeding. Right tool, wrong situation entirely.
Detox teas — the senna-based ones with cleanse branding. Stimulant laxatives speed up colonic transit, thin the mucosal layer, and flush out the commensal bacteria you're working to restore. It is mechanistically the exact opposite of post-antibiotic recovery.
Digestive-enzyme "cleanse" cocktails. Protease-lipase-amylase blends help with meal-time digestion in pancreatic insufficiency. They offer no mechanism for microbiome restoration, barrier repair, or dysbiosis correction. Real use case, wrong protocol.
Antimicrobial herbs during the restoration phase. Oregano oil (carvacrol + thymol), berberine, and garlic extract all have documented antimicrobial activity against gram-positive and gram-negative organisms — and that includes Lactobacillus and Bifidobacterium. Reseeding while you're also dosing antimicrobials can become self-cancelling. If you take berberine for cardiometabolic reasons, do not stop clinician-directed use because of this page; discuss spacing or a temporary pause during the 4–6 week restoration window with the clinician who knows why you take it.
Colonic irrigation / hydrotherapy. No RCT evidence supports it for post-antibiotic microbiome restoration, and the documented risks include electrolyte imbalance and mechanical perforation. In this window specifically, the flush strips out the commensal populations and probiotic strains you just spent good money introducing.
Frequently Asked Questions
How long does gut microbiome recovery after antibiotics take?
For a single broad-spectrum course, most studies show substantial restoration within 4–8 weeks. Stack multiple sequential courses, though, and reduced diversity can linger at 6 months. What moves the needle: antibiotic class and duration, your baseline microbiome diversity, dietary fiber intake, and whether you run a concurrent probiotic. This protocol is built for that 4–8 week active recovery window.
Can I take probiotics while still on antibiotics?
Yes, with one wrinkle per item. Saccharomyces boulardii CNCM I-745 (Florastor): yes, and no separation required — it's a yeast, so antibacterials don't touch it, which is exactly why it leads the protocol. Lactobacillus rhamnosus GG (Culturelle): yes, but take it at least 2 hours after each antibiotic dose, because LGG is a bacterium and is susceptible to antibacterials. The concurrent window is worth respecting — the dysbiotic shift starts within 24–48 hours of the first antibiotic dose.
Do I need all four items, or is one probiotic enough?
Depends on the course you ran. For a 7-day broad-spectrum course with significant GI symptoms, the full stack is warranted. For a 3-day narrow-spectrum course with minimal symptoms, S. boulardii plus LGG is likely sufficient. The four items aren't redundant — they cover different mechanisms and different timing windows: S. boulardii handles the concurrent and bridging window, LGG handles the reseeding phase, PHGG feeds the reseeded strains, and glutamine supports epithelial repair.
Why does strain ID matter — isn't a high CFU count what matters?
CFU count is the dose; it says nothing about mechanism. Lactobacillus rhamnosus GG ATCC 53103 has SpaC pili that mediate specific epithelial adhesion; a different L. rhamnosus strain without those pili has different biology and different clinical outcomes. The RCTs that produced the NNT = 10 data for S. boulardii and the RR = 0.58 data for LGG were run on specific strains. The product has to match the trial strain to inherit the evidence — otherwise you're borrowing someone else's results.
Is this protocol safe alongside other supplements?
For most common combinations, yes — at these doses, in otherwise-healthy adults. Two things to flag: if you're on anticoagulants (warfarin, apixaban, rivaroxaban), high-dose probiotic use can transiently affect vitamin K production, so raise it with your prescriber. And if you're on immunosuppressant medication, read the S. boulardii skip conditions before you start. The four protocol items themselves have clean safety profiles at the stated doses.
What should I eat during the restoration window?
Give PHGG something to work with: it performs best against a background of reasonable dietary fiber diversity. Aim for 150+ g of diverse plant fiber per week — legumes, oats, root vegetables, brassicas, berries. PHGG adds to dietary fiber; it doesn't replace it. And ease off alcohol and ultra-processed foods, which impair mucosal recovery in this window — alcohol directly reduces MUC2 mucin expression, and polysorbate-80 emulsifiers alter mucus-layer thickness.
What if I had C. diff — not just regular antibiotic-associated diarrhea?
Then the picture changes materially, and this is the one place we'd ask you to stop and not self-direct. The S. boulardii RCT evidence covers C. diff prevention, not treatment of active infection. Probiotic timing relative to fidaxomicin or vancomycin isn't well-characterized. For recurrent CDI, fecal microbiota transplant evaluation is often the appropriate next step, not a commercial probiotic protocol. Running this protocol on your own after a confirmed CDI is not appropriate — consult gastroenterology first.
Evidence — key citations
- McFarland LV, et al. JAMA 1994 — randomized placebo-controlled trial: recurrent C. diff relapse 34.6% with S. boulardii vs 64.7% placebo (RR 0.43); no significant benefit for first episodes (19.3% vs 24.2%, p=0.86).
- Goldenberg JZ, et al. Cochrane Database of Systematic Reviews 2015/2017 — probiotics reduced antibiotic-associated and C. diff-associated diarrhea risk, with absolute benefit concentrated in higher-risk groups.
- Hempel S, et al. JAMA 2012 — 63 RCTs, 11,811 participants: probiotics overall RR 0.58 for antibiotic-associated diarrhea.
- Szajewska H, Kołodziej M. Aliment Pharmacol Ther 2015 — LGG AAD prevention effect concentrated at ≥10¹⁰ CFU/day and significant primarily in children.
- Suez J, et al. Cell 2018;174(6):1406–1423 — an 11-strain probiotic delayed and impaired native mucosal microbiome recovery after antibiotics versus spontaneous recovery; autologous FMT restored fastest.
- Inulin-type fructans and post-antibiotic recovery (PubMed 32813896), 2020 — inulin-type fructan supplementation delayed recovery of antibiotic-induced colitis, supporting delayed prebiotic timing.
- Gorbach SL, Goldin BR; Zheng et al. — LGG (ATCC 53103) isolate/provenance and later Lacticaseibacillus rhamnosus reclassification; establishes the exact strain designation buyers should verify.
Build your stack
Tap to add any of these to your stack — or add the whole protocol at once, and skip anything you already own. Everything you add saves on your device; shop your stack whenever you're ready. Stack-kit stays the guide; the store handles checkout, shipping, and any subscription.
Adding is free and stays on your device. When you shop your stack we earn a small commission — same price for you, and it keeps the protocol free. We don't sell or ship supplements ourselves; the store handles checkout and shipping.
Affiliate Disclosure
Stack-kit earns affiliate commission on purchases made through links on this page. Brands earn protocol slots based on strain ID verification, NSF or equivalent third-party certification, and clinical trial correspondence — not by paying for placement. The Florastor, Culturelle, Sunfiber, and Thorne Research recommendations here reflect those criteria. We don't accept payment for protocol inclusion. Commission rates are standard affiliate rates, typically 5–15% of purchase price, at no additional cost to you.